Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders
Lysosomal storage disorders, characterized by altered metabolism of heparan sulfate, cause autistic symptoms followed by dementia in children. Here, the authors show that embryonic dopaminergic neurodevelopmental defects due to altered function of heparan sulfate cause autistic behaviours in mice.
Guardado en:
Autores principales: | Maria De Risi, Michele Tufano, Filomena Grazia Alvino, Maria Grazia Ferraro, Giulia Torromino, Ylenia Gigante, Jlenia Monfregola, Elena Marrocco, Salvatore Pulcrano, Lea Tunisi, Claudia Lubrano, Dulce Papy-Garcia, Yaakov Tuchman, Alberto Salleo, Francesca Santoro, Gian Carlo Bellenchi, Luigia Cristino, Andrea Ballabio, Alessandro Fraldi, Elvira De Leonibus |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ebeb3f36eeb489b8e165e8571b181e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Heparan Sulfate-Dependent Enhancement of Henipavirus Infection
por: Cyrille Mathieu, et al.
Publicado: (2015) -
AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
por: Francesca Gatto, et al.
Publicado: (2017) -
Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
por: Jihuan Chen, et al.
Publicado: (2017) -
Heparan sulfate proteoglycans present PCSK9 to the LDL receptor
por: Camilla Gustafsen, et al.
Publicado: (2017) -
mTOR-dependent phosphorylation controls TFEB nuclear export
por: Gennaro Napolitano, et al.
Publicado: (2018)